Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Statistics

Total Valuation

KYTX has a market cap or net worth of $619.22 million. The enterprise value is $369.00 million.

Market Cap	619.22M
Enterprise Value	369.00M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

KYTX has 60.53 million shares outstanding. The number of shares has increased by 15.46% in one year.

Current Share Class	60.53M
Shares Outstanding	60.53M
Shares Change (YoY)	+15.46%
Shares Change (QoQ)	+8.62%
Owned by Insiders (%)	1.75%
Owned by Institutions (%)	38.97%
Float	35.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.66
P/TBV Ratio	2.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.75, with a Debt / Equity ratio of 0.12.

Current Ratio	7.75
Quick Ratio	7.65
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-347.29

Financial Efficiency

Return on equity (ROE) is -64.67% and return on invested capital (ROIC) is -39.60%.

Return on Equity (ROE)	-64.67%
Return on Assets (ROA)	-35.47%
Return on Invested Capital (ROIC)	-39.60%
Return on Capital Employed (ROCE)	-65.99%
Weighted Average Cost of Capital (WACC)	14.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.24M
Employee Count	130
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +384.83% in the last 52 weeks. The beta is 2.06, so KYTX's price volatility has been higher than the market average.

Beta (5Y)	2.06
52-Week Price Change	+384.83%
50-Day Moving Average	8.94
200-Day Moving Average	7.22
Relative Strength Index (RSI)	60.34
Average Volume (20 Days)	1,271,212

Short Selling Information

The latest short interest is 5.16 million, so 8.53% of the outstanding shares have been sold short.

Short Interest	5.16M
Short Previous Month	4.23M
Short % of Shares Out	8.53%
Short % of Float	14.66%
Short Ratio (days to cover)	4.28

Income Statement

Revenue	n/a
Gross Profit	-133.72M
Operating Income	-169.83M
Pretax Income	-161.31M
Net Income	-161.31M
EBITDA	-168.03M
EBIT	-169.83M
Earnings Per Share (EPS)	-$3.64

Balance Sheet

The company has $279.25 million in cash and $29.03 million in debt, with a net cash position of $250.22 million or $4.13 per share.

Cash & Cash Equivalents	279.25M
Total Debt	29.03M
Net Cash	250.22M
Net Cash Per Share	$4.13
Equity (Book Value)	232.28M
Book Value Per Share	3.85
Working Capital	246.47M

Cash Flow

In the last 12 months, operating cash flow was -$153.71 million and capital expenditures -$5,000, giving a free cash flow of -$153.72 million.

Operating Cash Flow	-153.71M
Capital Expenditures	-5,000
Depreciation & Amortization	1.80M
Net Borrowing	23.89M
Free Cash Flow	-153.72M
FCF Per Share	-$2.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.46%
Shareholder Yield	-15.46%
Earnings Yield	-26.05%
FCF Yield	-24.82%

Analyst Forecast

The average price target for KYTX is $20.75, which is 102.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.75
Price Target Difference	102.84%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1